Lifetime Dedicated To Saving Sight

Centre for Eye Research Australia

When Professor Hugh Taylor AC founded CERA, he set out to challenge what many accepted as inevitable: blindness.

He believed that no one should lose their sight to a preventable condition, that a future free from avoidable blindness was within reach. And he's been driven by this belief for more than 50 years now, dedicating his career to tackling blindness – not only through scientific discovery, but by addressing the barriers that prevent people from accessing care.

The belief that changed eye health in Australia

While studying medicine and ophthalmology at the University of Melbourne in the mid to late 1970s, Professor Taylor was confronted by the devastating impact of trachoma - the leading infectious cause of blindness in Aboriginal and Torres Strait Islander communities. The experience left a profound impression on him and sparked a lifelong commitment to improving eye health equity across Australia.

Back then, he had joined by Fred Hollows on a mission that would change the course of eye health in Australia.

What began with visits to remote Aboriginal and Torres Strait Islander communities evolved into a decades long effort to eliminate trachoma – the world's leading infectious cause of preventable blindness. Until recently Australia was the only High- Income Country to still have trachoma as a problem.

Through the dedication of communities, Aboriginal Community Controlled Health Organisations (ACCHO), researchers, clinicians, governments and philanthropic supporters, rates of trachoma in at-risk First Nations children fell dramatically, closing a significant health equity gap.

This year, Australia became the 30th country to eliminate trachoma as a public health problem - a landmark achievement led by Professor Taylor that demonstrates what is possible when research, community leadership and sustained partnership come together.

"Real and lasting change doesn't happen overnight. It comes from decades of collaboration, listening to communities and working together to remove barriers to care," he says.

"The progress we've seen in eye health equity demonstrates the impact we can have when we share a common commitment to preventing avoidable vision loss."

A legacy of progress. A future of possibility.

Professor Taylor's research and advocacy have transformed eye health in Australia, helping to drive major reforms in eye care delivery and improve the lives of countless people. His extraordinary contributions have been recognised nationally and internationally, including his appointment as a Companion of the Order of Australia (AC) – the nation's highest civilian honours.

As CERA's founding Managing Director, he helped establish a culture that valued both scientific excellence and real-world impact. Under his leadership, we expanded our research programs and addressed some of the most significant challenges in vision loss and blindness.

Reflecting on the remarkable progress made over the past three decades, Professor Taylor says:

"Thirty years ago, cataracts was a major cause of blindness and surgery required a week in hospital. Macular degeneration could not be treated, and glaucoma patients relied on eye drops multiple times a day. Today, it's entirely different."

Looking to the future, he is equally optimistic:

"Thirty years from now, the risk of developing these conditions will likely be identified years before symptoms appear. Through advances in genetics and precision medicine, many forms of vision loss may be prevented altogether. The research happening today is incredibly exciting. It has the potential to transform lives and spare millions from losing their sight."

Professor Taylor believes CERA is uniquely positioned to help lead that future.

"CERA is now recognised as one of the world's leading eye research centres. That's an extraordinary achievement and a testament to the talented researchers, clinicians and supporters who have come together around a shared vision. It also reflects the enormous opportunities that exist here in Melbourne to drive the next generation of breakthroughs in eye health."

Building something that would last

"Research only matters if it improves people's lives, and that can only happen when findings are translated into meaningful action and real-world impact," says Professor Taylor.

Reflecting on the changes he has witnessed during his career, Professor Taylor has seen eye health transformed.

When he began his work, many blinding eye diseases were poorly understood, and treatment options were limited. Today, advances in genetics, artificial intelligence and regenerative medicine are creating opportunities that once seemed unimaginable.

Just as importantly, eye research has become increasingly collaborative.

Researchers now work alongside clinicians, patients, communities and supporters to ensure discoveries address real-world needs and can be translated into meaningful outcomes. That spirit of collaboration is embedded in the organisation Professor Taylor founded three decades ago.

"The work on the genetics of inherited retinal diseases and glaucoma is amazing, unthinkable 30 years ago. Equally amazing are the synthetic corneas and the whole range of clinical trials, he says.

A legacy for future generations

Nearly 30 years after founding CERA, that vision remains as relevant as ever. And as new discoveries bring us closer to a future where blindness is preventable, his legacy continues to guide the path forward.

Although Professor Taylor stepped down from leading CERA many years ago, we continue to build on the foundations he created, with every new discovery and clinical trial reflecting the vision he set in motion when he established the institute in 1996.

His influence extends far beyond any single research project or institution. It can be found in communities where trachoma has been eliminated, in patients receiving earlier diagnoses and better treatments, and in the generations of researchers and clinicians inspired by his example.

For Professor Hugh Taylor AC, the goal has always been simple: give more people the opportunity to see, participate and thrive.

Read 30 days of stories, milestones, breakthroughs and reflections from the people who have shaped our journey and those building its future.

Professor Hugh R Taylor AC has spent decades protecting vision by bridging the lab and the clinic. His new autobiography captures that journey.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.